Filter Search


Healthcare and Medical


Location Summary Deadline
Germany Conclusion Of Non-exclusive Discount Agreements According To § 130a Para. 8 Sgb V For The Mentioned Active Ingredients With The Possibility Of Conclusion Within The Framework Of The So-called Open House Procedure. 2026-06-17
Germany Conclusion Not Excluding The Discount Agreement For Pharmaceuticals According To § 130a Para. 8 Sgb V In The Form Of An Open House Model For The Active Ingredient Timolol (atc Code According To Who 2026-06-17
Germany The Subject Of This Publication Is The Conclusion Of Non-exclusive Discount Agreements According To § 130a Abs. 8 Sgb V For Medicines Containing The Active Ingredient Latanoprost/timolol (official Atc Code: S01ed61), Excluding Medicines With Package Size 2026-06-17
Portugal Ct-25/01575 - Supply And Installation Lifting Platform Eb Belas 5 E Es Gama Barros 2026-06-17
Portugal Acquisition And Installation Of Electric Beds For The Orthopedics Service At Uls Lezíria, E.p.e 2026-06-17
Portugal 11503126 - Acquisition Of Reagents For The Study Of Hemoglobin Fractions 2026-06-17
Germany Conclusion Not Excluding Drug Discount Agreement. According To Section 130a Paragraph 8 Sgb V Through An Open House Model For The Active Ingredient Sultamicillin (atc Code According To Who: J01cr04) 2026-06-17
Germany Provision Of A Non-exclusive Discount Agreement For The Active Ingredient Fampridine Through An Open-house Model. Fampridine 2026-06-17
Germany Certolizumab Pegol 2026-06-18
Germany Conclusion Of A Non-exclusive Discount Agreement According To § 130a Para. 8 Sgb V For Pharmaceuticals Containing The Active Ingredient Propranolol (atc Code 2026-06-18
Whats app